#opioidusedisorder
AUTHORS' OWN WORDS: "Average #Buprenorphine daily dose(BDD) Trajectories for Episodes of #Buprenorphine Tx for #OpioidUseDisorder #OUD. BDD ranges widely & patient characteristics are significantly different between those episodes after differing BDD trajectories journals.sagepub.com/doi/abs/10.1...
December 1, 2024 at 2:53 PM
August 11, 2026 at 6:33 AM
Researchers from @ucsdmedschool.bsky.social found that Mindfulness-Oriented Recovery Enhancement (MORE) can help rewire the brain’s response to natural healthy pleasure, leading to reduced opioid cravings. MORE could be a promising tool in the fight against #OpioidUseDisorder.
May 21, 2025 at 11:35 PM
💬 Viewpoint: Nearly $57 billion in #opioid settlement funds is being spent variably across US jurisdictions, with many allocations not directed to evidence-based #OpioidUseDisorder interventions or harm reduction.

ja.ma/4qKph0y
February 19, 2026 at 12:00 PM
Patients with #OpioidUseDisorder reported that in-person methadone dosing visits required substantial travel time and cost, while wait times, clinic hours, and transportation barriers further limited treatment access. ja.ma/4hKL3Pb
October 9, 2026 at 10:30 AM
Among patients with #OpioidUseDisorder offered buprenorphine in the emergency department, declination was associated more with concerns about precipitated withdrawal, physical dependence, and housing barriers than with lower treatment readiness. ja.ma/4hKNeCl
October 9, 2026 at 11:00 AM
#Stigma is a larger problem than overuse of medication to treat #OpioidUseDisorder
(#SharedFacts #Semantics #OpioidCrisis #HumanReasoning #CollectiveBehavior
February 12, 2025 at 10:05 PM
Methadone isn’t one-size-fits-all. In this study, most patients preferred tablet over liquid—citing convenience, less stigma, and similar withdrawal control. Expanding formulations could improve treatment experience in OUD care. www.tandfonline.com/doi/full/10....
#OpioidUseDisorder #Methadone
May 5, 2026 at 2:54 PM
#Stigma is a larger problem than overuse of medication to treat #OpioidUseDisorder
#SharedFacts- #Semantics #OpioidCrisis #HumanReasoning #CollectiveBehavior
January 25, 2025 at 11:41 AM
@jessicamerlinmd.bsky.social joined @thecurbsiders.bsky.social to bust common myths and explore strategies to support patients with #ChronicPain and #OpioidUseDisorder.

Listen to the episode and access resources: thecurbsiders.com/curbsiders-p...
June 20, 2025 at 3:22 PM
AUTHORS' OWN WORDS: "They Ask ?s, But They Don’t Want the Answers”:Perceptions of Clinical Communication Among Veterans Discontinuing #Buprenorphine for the Treatment of #OpioidUseDisorder "...patient-centered communication...could improve the patient experience" journals.sagepub.com/doi/abs/10.1...
December 5, 2024 at 2:18 PM
🗣A Phase 1 trial shows virtual reality–based Mindfulness-Oriented Recovery Enhancement (MORE-VR) may reduce cravings, boost mood, and support medication-assisted treatment for opioid use disorder.

Find the study on the last slide! 💡

#OpioidUseDisorder #RecoverySupport #VirtualReality #Mindfulness
September 25, 2025 at 3:49 PM
Asst. Prof. Brandy Henry is advancing OUD care at #PennState through the Cascade of Care framework—highlighting treatment gaps & solutions to improve outcomes for those affected.

#OpioidUseDisorder #CascadeOfCare #PennStateEducation

ed.psu.edu/news/penn-st...
August 22, 2025 at 5:11 PM
Researchers from @ucsdmedschool.bsky.social found that Mindfulness-Oriented Recovery Enhancement (MORE) can help rewire the brain’s response to natural healthy pleasure, leading to reduced opioid cravings. #OpioidUseDisorder
Mindfulness Therapy Reduces Opioid Craving and Addiction, Study Finds
Researchers from UC San Diego found that Mindfulness-Oriented Recovery Enhancement (MORE) can help rewire the brain’s response to natural healthy pleasure, leading to reduced opioid cravings. The…
buff.ly
April 30, 2025 at 6:00 PM
AUTHORS' OWN WORDS: In the article "Physician’s Attitudes Toward Patients With #OpioidUseDisorder and Use of #MedicationsforOpioidUseDisorder Vary by Training"

journals.sagepub.com/doi/full/10....
January 16, 2025 at 7:30 PM
This month, we’re highlighting the work of our students and alumni addressing #OpioidUseDisorder.

Anna Stouffer, MPH ’24 and Liz Znamierowski, MSN '20 lead a drug-checking program through the Yale Community Health Care Van, analyzing street drugs with advanced technologies.🔍
November 25, 2024 at 1:21 PM
Among pregnant and postpartum individuals with #OpioidUseDisorder, longer duration of medications for opioid use disorder was associated with lower 1-year risk of overdose or death after delivery.

ja.ma/3VHFOse
Duration of Medication for Opioid Use Disorder and Postpartum Overdose and Death
This cohort study examines whether longer duration of medications for opioid use disorder dispensed during pregnancy and early post partum is associated with reduced overdose and death through 365 days post partum.
ja.ma
October 10, 2026 at 2:30 PM
Among Medicaid-enrolled youths with #OpioidUseDisorder, only 1 in 6 received medication for opioid use disorder and only 1 in 32 had 180 days or more of medication retention.

ja.ma/3VXzc9e
October 10, 2026 at 2:00 PM
April 9, 2026 at 11:39 PM
#Research Readings: Health Plan Disenrollment and Mortality After Initiation of Medications for #OpioidUseDisorder

https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2845753
May 20, 2026 at 4:01 PM
#MOUD myths like "replacing one opioid for another" discourage treatment. Dr. Paul Joudrey explains MOUD helps people be dependent, not addicted in a Pittsburgh Post-Gazette piece.

More about how PGH MOUD, a local group, is reducing stigma around #OpioidUseDisorder: https://buff.ly/3C7lc39
January 21, 2025 at 6:33 PM
Weekly extended-release buprenorphine for #OpioidUseDisorder in #pregnancy resulted in higher abstinence rates than sublingual buprenorphine, with similar maternal and neonatal safety outcomes.

ja.ma/3NmbT5e
March 17, 2026 at 2:00 PM